NRC — NRC HEALTH
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 70487 ·
Last close
$19.57
Market Cap
$432.88M
52W High
$23.49
52W Low
$10.65
ADV30
126,560
Next earnings
2026-10-26
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 35,194,000 | 21,259,000 | 4,669,000 | 1,798,000 | 134,878,000 | 4,139,000 | 120,888,000 |
| Sep 2025 | 34,608,000 | 22,204,000 | 7,738,000 | 4,122,000 | 135,719,000 | 2,219,000 | 121,405,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$29,509,000
Investing CF
$-7,868,000
Financing CF
$-23,588,000
CapEx
$-7,868,000
Dividends Paid
$-12,705,000
Buybacks
$-18,848,000
EPS Diluted TTM
$0.25
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-24,507,000
Inventory
—
Receivables
$13,649,000
ST Investments
—
EBIT TTM
$14,789,000
Pretax Income TTM
$9,384,000
Interest Exp TTM
$5,405,000
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$139,996,992
EBITDA
$26,675,000
Free Cash Flow
$20,282,000
Enterprise Value
$554,284,224
Total Cash
$3,327,000
Total Debt
$90,446,000
Shares Out
22,119,566
Trailing EPS
$0.24
Book Value
$0.30
ROE
42.0%
ROA
8.1%
Div Yield
3.03%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 137,390,000 | 22,590,000 | 11,600,000 | 134,878,000 | 120,888,000 | 13,990,000 | 26,450,000 |
| Dec 2024 | 143,060,000 | 35,194,000 | 24,783,000 | 132,539,000 | 101,255,000 | 31,284,000 | 34,625,000 |
| Dec 2023 | 148,580,000 | 40,045,000 | 30,971,000 | 122,437,000 | 73,482,000 | 48,955,000 | 38,113,000 |
| Dec 2022 | 151,568,000 | 46,543,000 | 31,800,000 | 130,461,000 | 58,428,000 | 72,033,000 | 36,265,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$1.05
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $17.50 · spot: $19.81 · call volume: 73 · put volume: 2
Expected Move to 2026-12-18:
±$2.85
(14.39%) —
implied range
$16.96 –
$22.66
· ATM straddle on $20.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MYGN | MYRIAD GENETICS INC | $398.86M | $4.17 | — |
| TKNO | Alpha Teknova, Inc. | $500.91M | $9.33 | — |
| OABI | OmniAb, Inc. | $670.25M | $4.61 | — |
| NNNN | Anbio Biotechnology | $276.51M | $6.30 | — |
| QDEL | QuidelOrtho Corp | $750.22M | $10.94 | — |
News headlines (Yahoo Finance, 1h cache)
NRC Health's Dividend Analysis
2026-09-25 11:04 · Yahoo
The Governance Institute Blue Ribbon Committee Reframes Hospital and Health System Board Assessment with Four Considerations for Stronger Governance
2026-09-21 14:45 · Yahoo
KLAS First Look: NRC Health Rounding Earns 91.6 Overall Performance Score
2026-09-02 19:00 · Yahoo
NRC Health Announces 2026 Award Winners Recognizing Excellence Across Healthcare
2026-09-01 13:00 · Yahoo
New NRC Health Research Reveals What Drives Patient Loyalty Beyond Access
2026-07-30 13:00 · Yahoo
NRC Health (NRC) Q2 2026 Earnings Call Highlights: Strong TRCV Growth Amid Market Uncertainty
2026-07-29 05:01 · Yahoo
NRC Health Trades at a Discount: Should You Buy, Sell or Hold?
2026-09-28 16:35 · Yahoo
Resideo Appoints Shane Harrison as Chief Financial Officer
2026-08-12 20:06 · Yahoo
Record Backlog Powers NRC Health’s (NRC) Upward Potential
2026-08-10 15:34 · Yahoo
NRC Down 8% Despite Q2 Earnings Rising Y/Y on TRCV Growth
2026-08-03 17:53 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.